Lantern Pharma Inc. (LTRN)
NASDAQ·Healthcare·Biotechnology
$0.56
-1.37%
Mkt Cap $29.86M
No analyst coverage available
We don't have analyst ratings or price target data for Lantern Pharma Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.